Punjab’s pharmaceutical landscape is thriving, with rising healthcare demands creating prime opportunities for entrepreneurs. Arlak Biotech, a leading PCD Pharma Franchise provider, offers monopoly-based franchises in the region, backed by WHO-GMP certified products and comprehensive support. This PCD Pharma Franchise model allows partners to build sustainable businesses with low investment, high margins (25–40%), and exclusive territorial rights.
RESPILAK
RESPILAK is Arlak Biotech’s specialized division dedicated to respiratory health, offering a comprehensive range of innovative formulations for conditions like asthma, bronchitis, COPD, and allergic rhinitis. As part of our PCD Pharma Franchise ecosystem, RESPILAK includes bronchodilators, mucolytics, antihistamines, and combination therapies in forms like inhalers, nebulizers, tablets, and syrups. Developed with advanced R&D, these products ensure quick relief, minimal side effects, and compliance with DCGI standards, making them ideal for franchise partners targeting high-prescription segments in Punjab’s urban and rural markets.
NEURATO – Neuropsychiatric Division
NEURATO, Arlak Biotech’s Neuropsychiatric Division, focuses on mental health and neurological support with a portfolio of over 50 products addressing anxiety, depression, epilepsy, schizophrenia, and cognitive disorders. For PCD Pharma Franchise partners, NEURATO offers antidepressants, anxiolytics, antipsychotics, and mood stabilizers in tablets, capsules, and injectables, all GMP-certified for efficacy and safety. This division taps into the growing mental health awareness in Punjab, providing franchisees with high-margin, repeat-prescription items supported by detailed marketing aids.
Arlak Kids Edition
Arlak Kids Edition is our pediatric-focused range, designed for children’s health with gentle, palatable formulations for immunity, growth, digestion, and common illnesses. Tailored for PCD Pharma Franchise in Punjab, it includes syrups, drops, powders, and multivitamin chews like paracetamol suspensions, antibiotic liquids, and nutritional supplements. DCGI-approved and flavor-enhanced for compliance, this edition helps franchise partners capture the lucrative paediatric market, where parental trust drives consistent sales.
3rd Party Manufacturing
Arlak Biotech’s 3rd Party Manufacturing services enable brands to outsource high-quality production without infrastructure costs. As a key enabler for PCD Pharma Franchise, we offer end-to-end solutions in GMP-certified facilities, covering formulation development, packaging (blisters, bottles, cartons), and quality testing for tablets, capsules, syrups, injectables, and ointments. Partners in Punjab benefit from low MOQ, quick turnaround, and customization, ensuring scalable growth.
Facilities to Pharma PCD Party, Franchise, Marketing Team and Distributors
We provide extensive facilities to Pharma PCD Party, Franchise, Marketing Team, and Distributors, including monopoly rights, free promotional kits (visual aids, samples, MR bags, calendars), training programs, digital marketing tools, and timely pan-India logistics. For PCD Pharma Franchise in Punjab, this includes field support, performance incentives, and inventory management, empowering partners to achieve 30%+ ROI with minimal hassle.
Ayurvedic PCD Franchise
Our Ayurvedic PCD Franchise leverages traditional herbal wisdom with modern science, offering 100+ natural products like churnas, oils, tablets, and syrups for immunity, joint health, digestion, and wellness. Integrated into our PCD Pharma Franchise model for Punjab, it includes AYUSH GMP-certified formulations with monopoly rights, high margins, and promotional support, ideal for tapping the growing demand for chemical-free alternatives.
Conclusion
Arlak Biotech redefines success in PCD Pharma Franchise with specialized divisions like RESPILAK, NEURATO, Arlak Kids Edition, robust 3rd party manufacturing, and dedicated facilities for partners. Our ayurvedic offerings further enhance profitability in Punjab’s dynamic market. Partner with Arlak Biotech to unlock sustainable growth and deliver quality healthcare solutions.
